INTRODUCTION
We have reported that radiotherapy treatment planning using heterogeneity corrections for 5-bulk densities can be used in place of heterogeneity-corrected computed tomography (CT) treatment planning even in the thoracic area. 1 The application utilises an on-board image-guided radiation therapy (IGRT) device that is under development. 2 This IGRT device will utilise magnetic resonance imaging (MRI) in real time (taken during radiation delivery) to compute the dose delivered to the patient. Whereas segmented MRI studies can be used to identify bulk-density regions of air, lung, fat, soft tissue, and bone in a patient; the non-bone highdensity regions of CT images are not easily identified with this technique. Instead of using CT-based treatment planning for the thoracic area, the 5-bulkdensity method can be used without electron-density information. However, if an MRI is used for treatment planning, [3] [4] [5] [6] [7] small calcified regions, such as those in the aortic wall, are impossible to identify. This common condition is found in many patients undergoing CT simulation for radiation therapy.
In our previous study, 1 we created a bone-density region using an auto-contouring tool for which we established a threshold density and then automatically contoured all of the structures that had a higher CT number than the threshold of 1080 HU. These structures included small calcifications, artefacts caused by high-density lesions, and higher-density areas in the soft tissue that could not be visualised when an MRI was used for treatment planning. The CT number of the Pinnacle 3 treatment planning system (Philips Medical Systems, Andover [MA], USA), which we used for this and the previous study, is equal to 0 for air density.
The purpose of this study was to investigate whether the results of the 5-bulk-density dose calculation were significantly affected by these small non-bone highdensity areas, which would be ignored when the contouring was done manually.
METHODS
This study analysed anonymised CT planning image studies for lung and oesophageal cancers demonstrating gross tumour volumes treated at the University of Florida, Gainesville [FL], USA. These patients were the same as in our previous study.
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A l l p a t i e n t s h a d u n d e r g o n e h e l i c a l C T s c a n s (Professional Series P220F; Philips Medical Systems, Eindhoven, The Netherlands) without contrast enhancement and with an axial-plane image-matrix size of 512 x 512, an in-plane pixel size of 1.1 mm, and a slice thickness of 3.0 mm covering the entire thorax and the superior portion of the abdomen. No intravenous contrast enhancement was used. However, to enhance the image, one patient with oesophageal cancer was administered barium sulphate cream (Esopho-cat 3.0%; E-Z-EM Canada Inc, Montreal, Canada). While in a sitting position on the CT simulation table, the patient swallowed one teaspoon of the contrast material then, while lying on the table, the patient swallowed half a teaspoon immediately before the scan was taken.
Heterogeneity-corrected CT resolution and bulkelectron-density treatment plans were generated for the patients using a commercial treatment planning system with an adaptive convolution dose-calculation algorithm (Pinnacle
3
) and employing an isotropic 4-mm dose-calculation grid. For each patient, bulk-electron densities were applied to regions identified by an isodensity segmentation tool. The word 'density' is used to indicate electron density relative to that of water. 1 In brief, the trachea, lung, fat, and bone were contoured and the soft-tissue-density region was generated by subtracting these contours from the body contour. The population-average data of 66 patients determined the electron density for each region; the densities assigned to air, lung, fat, soft tissue, and bone were 0.14, 0.26, 0.89, 1.02, and 1.12 g/cm 3 , respectively. For patients with specific pathological conditions such as bullous formations, pneumothorax or hiatus hernia, the density of air was assigned to the pathological regions.
For each patient, three plans were created: (1) a heterogeneity-corrected CT plan that was referred to as the original plan ( Figure 1a) ; (2) an autocontoured bone plan, for which the bone was contoured automatically using the threshold 1080-4500 HU using the 5-bulk densities ( Figure 1b) ; and (3) a manually contoured bone plan, for which the bone was contoured manually using the 5-bulk densities ( Figure 1c ). Implantable port reservoirs were contoured for the bones, but calcifications, CT artefacts, highdensity areas in the soft tissue, and oral contrast media for the gastrointestinal tract were excluded. All plans were simple, with two opposed 10-MV beams (at 0° and 180°) and no intensity-modulated radiation therapy (IMRT) or stereotactic body radiotherapy was employed. The weighting was the same for both beams. Original monitor units were used for all three plans, and no normalisations or adjustments were made. Dose-volume histogram (DVH) and slice-by-slice comparisons of dosimetry for the treatment area were performed for all plans. We specifically investigated the following parameters: the dose covering 95% or more (D95) of the planning target volume (PTV); the mean PTV dose; the percentage of the total lung volume receiving 20 Gy or higher (V20Gy %); and the mean total lung dose. If the dose or volume differences were within 2% of the original plan, the plan was regarded as acceptable. For the slice-by-slice comparisons, we calculated the percentage of dose-grid voxels that showed more than 5% disagreement in the area with less than 3% of the maximum dose gradient.
RESULTS
Fifty-three patients with 57 tumours were enrolled in the study. Table 1 shows the patients' demographics. All patients who attended the Department of Radiation Oncology for thoracic radiotherapy were included except for those who underwent IMRT or stereotactic body radiotherapy. Tables 2 and 3 summarise the mean and percentage differences in dose volume between the three plans. In general, no significant differences were observed for either the PTV or critical-structure doses. For the critical structures, which included the lung, heart and spinal cord, no differences greater than 2% in either dose or volume were observed in any of the DVHs. Figure 2 shows a DVH for a typical patient, with good agreement between the plans (the DVH of the three plans are displayed as an overlay). There were no differences greater than 2% between the original and manual plans (the largest difference observed was 1.85% in the mean PTV dose). Moreover, there were no differences greater than 1% between the auto-contoured and manual plans (the largest difference observed was 0.62% in D95 of the PTV).
In addition, in the slice-by-slice comparisons of Table 3 . Differences (in Gy) of D95, mean dose of PTV, and V20Gy, and mean dose to lung between original heterogeneity-corrected computed tomography plans (original), 5-bulk-density plans in which the bones are automatically contoured (auto-contoured), and 5-bulkdensity plans in which the bones are manually contoured (manual).
Abbreviations: PTV = planning target volume; SD = standard deviation. * No. of tumours where the difference was ≥2%. † PTV D95 represents the dose covering ≥95% of the PTV. ‡ Lung V20Gy represents the percentage of lung volume covered by ≥20 Gy. dosimetry for the treatment areas (for both the original vs manual and the auto-contoured vs. manual plans), no cases showed >1% of the voxels with >5% of dose difference in a low-gradient region (original vs. manual mean, 0.18%; standard deviation [SD], 0.23%; autocontoured vs. manual mean, 0.10%; SD, 0.19%).
DISCUSSION
The 5-bulk-density dose calculation method 1 eliminates the need for electron-density information, even for the thoracic area. However, some issues arise when the method is used for MRI treatment planning. MRI is less sensitive to calcification than CT; thus, CT imaging can identify small calcifications such as those of the large vessels (Figures 1a, 1b, and 3) , and high-density regions such as the thyroid gland that MRI cannot identify. Furthermore, MRI is unable to detect CT-identifiable, non-calcified, high-density areas, such as soft tissue in the superior region of the thorax (Figure 4) or contrast in the oesophagus ( Figure 5 ).
Patients who repeatedly receive chemotherapy sometimes have an implantable port reservoir inserted.
An implantable port reservoir is easy to detect on both CT and MRI; therefore, we contoured them as 'bone' in the manual plan ( Figure 6 ). However, the catheters connected to them, which contain high-density material, are easy to detect on CT, but not on MRI (Figures 7a  and 7b) . Also, there are CT-detectable artefacts caused by these kinds of high-density regions (Figure 7c ) that are seen during treatment planning, but do not actually exist, as well as oral contrast-enhancement materials that disappear after treatment planning. In these situations, the manual plan is more accurate than the auto-contoured plan, since the auto-contoured plan may detect artefacts in high-density regions that do not exist during the treatment.
In our previous study, we used an automated method to contour bone. 1 With this method, the high-density areas above a certain threshold were included in the bonedensity region. The purpose was to investigate whether or not the 5-bulk-density dose calculation method would be compromised if the MRI-detectable region was manually contoured and assigned as bone density. When we compared the manual with the original plan DVH, we found that there were no patients for whom a ≥2% difference was seen in either dose or volume for either the PTV or critical organs. The difference between the manual and auto-contoured plans, with a maximum difference of 0.62% in D95, was even less. In the slice-by-slice comparisons for both the original versus manual and auto-contoured versus manual plans, no cases showed >1% of the voxels with a >5% difference in a low-gradient region (maximum, 0.96% and 0.77%, respectively). Of the 12 oesophageal cancer patients, 10 had contrast material in the PTV; nine patients had large calcifications in the PTV, and three patients had postoperative clips with strong artefacts; nevertheless, the effect of these conditions on the dosimetry was not significant.
Presently, even in the thoracic area of treatment and especially for stereotactic body radiotherapy, more than 2 beams are employed. However, only opposing beams of 10-MV photons with entry angles at 0º and 180º (same weighting) were studied. This is because the simple direct beams would be more affected by the high-density areas. Had more complicated planning such as 3-dimensional, IMRT, or Volume Activation Management Tool been used, the beams entering from several directions and the modulated intensity would have offset the effect from the high-density area because the high-density areas exist only in restricted, relatively small, areas.
Even if the bones were manually contoured and the small calcifications and high-density areas in the body were assigned as soft-tissue density, the heterogeneity correction for 5-bulk densities could still be used for accurate radiotherapy treatment planning. Thus, this method could be employed for treatment planning using MRI, for which the sensitivity to calcification is lower than that for CT.
CONCLUSION
For treatment planning done with an IGRT device without electron-density information provisions, even if the small high-density regions are not detectable, bulk-tissue-density heterogeneous dose calculation can enable clinically acceptable dosimetric accuracy for auto-contoured bone without considering small nonbone high-density regions.
